PIN1 and cancer: Given that Pin1 plays an essential role in the maintenance of a cancer stem-cell phenotype, combination therapies that include a Pin1 inhibitor are an attractive approach to sensitizing drug-resistant CSCs to treatment with cytotoxic agents that were not effective in the absence of Pin1 inhibition.